Standout Papers

Development of NK cell-based cancer immunotherapies through receptor engineering 2023 2026 2024190
  1. Development of NK cell-based cancer immunotherapies through receptor engineering (2024)
    Audrey Page, Nicolas Chuvin et al. Cellular and Molecular Immunology
  2. TCR-engineered T cell therapy in solid tumors: State of the art and perspectives (2023)
    Nicolas Chuvin, Stéphane Depil et al. Science Advances

Immediate Impact

4 from Science/Nature 71 standout
Sub-graph 1 of 23

Citing Papers

Macrophage plasticity: signaling pathways, tissue repair, and regeneration
2024 Standout
Fibroblast and myofibroblast activation in normal tissue repair and fibrosis
2024 Standout
5 intermediate papers

Works of Nicolas Chuvin being referenced

Tenascin-X promotes epithelial-to-mesenchymal transition by activating latent TGF-β
2014

Author Peers

Author Last Decade Papers Cites
Nicolas Chuvin 200 228 254 10 465
Pilvi Maliniemi 237 138 259 16 487
Stacy K. Thomas 258 133 152 12 437
Philippe Vielh 186 170 172 13 531
Christian Augsberger 175 191 269 9 464
Richard Kay 269 99 168 14 552
Marie-Chantal Grégoire 244 113 120 21 466
Annalisa Rossini 223 196 190 8 489
In-San Kim 271 75 94 7 416
Eric Routhier 174 100 162 11 504
S. O. Yim 316 82 163 9 496

All Works

Loading papers...

Rankless by CCL
2026